BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis, and structure-activity relationship studies of highly potent novel benzoxazinyl-oxazolidinone antibacterial agents. 2011

Qisheng Xin, and Houxing Fan, and Bin Guo, and Huili He, and Suo Gao, and Hui Wang, and Yanqin Huang, and Yushe Yang
Shanghai Institute for Biological Sciences , Chinese Academy of Sciences, Shanghai, China.

A series of novel benzoxazinyl-oxazolidinones bearing nonaromatic heterocycle or aryl groups were designed and synthesized. Their in vitro and in vivo antibacterial activities were investigated. Most of the (3S, 3aS) biaryl benzoxazinyl-oxazolidinones exhibited potent activity against Gram-positive pathogens. SAR trends were observed; a pyridyl C ring was preferable to other 5- or 6-member aryl C rings, while fluorine substitution on the B ring generated derivatives with reduced activity. Various substituent group positions on the pyridyl ring were also evaluated. The resulting compounds displayed excellent activity against linezolid-resistant strains. Compound 45 exhibited excellent in vitro activity, with a MIC value of 0.25-0.5 μg/mL against MRSA and an activity against linezolid-resistant strains of 8-16-fold higher potency than linezolid. In a MRSA systemic infection model, compound 45 displayed an ED(50) < 5.0 mg/kg, a potency that is nearly 3-fold better than that of linezolid. This compound also showed excellent pharmacokinetic profiles, with a half-life of more than 5 h as well as an oral bioavailability of 81% in rats.

UI MeSH Term Description Entries
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D005260 Female Females
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D000069349 Linezolid An oxazolidinone and acetamide derived ANTI-BACTERIAL AGENT and PROTEIN SYNTHESIS INHIBITOR that is used in the treatment of GRAM-POSITIVE BACTERIAL INFECTIONS of the skin and respiratory tract. Linezolide,N-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide,PNU-100766,U 100766,U-100766,Zyvox,100766, U,PNU 100766,PNU100766,U100766
D000081 Acetamides Derivatives of acetamide that are used as solvents, as mild irritants, and in organic synthesis.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections

Related Publications

Qisheng Xin, and Houxing Fan, and Bin Guo, and Huili He, and Suo Gao, and Hui Wang, and Yanqin Huang, and Yushe Yang
Synthesis and structure-activity relationship studies of highly potent novel oxazolidinone antibacterials.
October 2008, Journal of medicinal chemistry,
Qisheng Xin, and Houxing Fan, and Bin Guo, and Huili He, and Suo Gao, and Hui Wang, and Yanqin Huang, and Yushe Yang
Synthesis and structure-activity studies of novel homomorpholine oxazolidinone antibacterial agents.
January 2009, Bioorganic & medicinal chemistry letters,
Qisheng Xin, and Houxing Fan, and Bin Guo, and Huili He, and Suo Gao, and Hui Wang, and Yanqin Huang, and Yushe Yang
Synthesis and structure-activity studies of novel benzocycloheptanone oxazolidinone antibacterial agents.
October 2006, Bioorganic & medicinal chemistry letters,
Qisheng Xin, and Houxing Fan, and Bin Guo, and Huili He, and Suo Gao, and Hui Wang, and Yanqin Huang, and Yushe Yang
Design, synthesis, and structure-activity relationship studies of novel thioether pleuromutilin derivatives as potent antibacterial agents.
June 2014, Journal of medicinal chemistry,
Qisheng Xin, and Houxing Fan, and Bin Guo, and Huili He, and Suo Gao, and Hui Wang, and Yanqin Huang, and Yushe Yang
Synthesis and structure-activity relationship studies of novel [6,6,5] tricyclic oxazolidinone derivatives as potential antibacterial agents.
January 2015, Bioorganic & medicinal chemistry letters,
Qisheng Xin, and Houxing Fan, and Bin Guo, and Huili He, and Suo Gao, and Hui Wang, and Yanqin Huang, and Yushe Yang
Design, synthesis, and structure-activity relationship studies of novel millepachine derivatives as potent antiproliferative agents.
August 2012, European journal of medicinal chemistry,
Qisheng Xin, and Houxing Fan, and Bin Guo, and Huili He, and Suo Gao, and Hui Wang, and Yanqin Huang, and Yushe Yang
6-Cinnamoyl-4-arylaminothienopyrimidines as highly potent cytotoxic agents: Design, synthesis and structure-activity relationship studies.
January 2020, European journal of medicinal chemistry,
Qisheng Xin, and Houxing Fan, and Bin Guo, and Huili He, and Suo Gao, and Hui Wang, and Yanqin Huang, and Yushe Yang
Structure-activity relationship (SAR) studies on oxazolidinone antibacterial agents. 1. Conversion of 5-substituent on oxazolidinone.
April 2001, Chemical & pharmaceutical bulletin,
Qisheng Xin, and Houxing Fan, and Bin Guo, and Huili He, and Suo Gao, and Hui Wang, and Yanqin Huang, and Yushe Yang
Structure-activity relationship (SAR) studies on oxazolidinone antibacterial agents. 3. Synthesis and evaluation of 5-thiocarbamate oxazolidinones.
April 2001, Chemical & pharmaceutical bulletin,
Qisheng Xin, and Houxing Fan, and Bin Guo, and Huili He, and Suo Gao, and Hui Wang, and Yanqin Huang, and Yushe Yang
Design, Synthesis, and Structure-Activity Relationship Studies of New Quinone Derivatives as Antibacterial Agents.
June 2023, Antibiotics (Basel, Switzerland),
Copied contents to your clipboard!